Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus

Código QR

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus

Article reviews basic steps and regimens of insulin analogue therapy intensification in patients with type 2 diabetes mellitus (T2DM). Intensification of insulin therapy is commonly implemented by supplementation of basal insulin with prandial before breakfast, lunch and dinner. Updated EASD/ADA gui...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alexander Sergeevich Ametov, Natalya Al'bertovna Chernikova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	type 2 diabetes mellitus insulin therapy intensification diabetes training self-monitoring insulin analogues Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/90440358dfe04714be859f1b55dd0f1f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
por: Elena V. Buryukova, et al.
Publicado: (2017)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study
por: Marina V. Shestakova, et al.
Publicado: (2016)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
por: Natalya Nikitichna Volevodz, et al.
Publicado: (2013)

Modern basal insulins: an ongoing story or the start of a new era?
por: Ivan Ivanovich Dedov
Publicado: (2015)

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
por: Irina A. Proskurina, et al.
Publicado: (2016)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
por: M. V. Shestakova, et al.
Publicado: (2021)

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
por: Vladimir Ivanovich Kudinov, et al.
Publicado: (2012)

A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
por: Marina Vladimirovna Shestakova
Publicado: (2012)

A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus
por: Marina V. Shestakova, et al.
Publicado: (2016)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Efficacy and safety of treatment with human insulin analogues in daily management of insulin naive patients with type 2 diabetes mellitus: results of multicenter 52-week observational study A1chive
por: Marina Vladimirovna Shestakova
Publicado: (2012)

On the centenary of the insulin discovery
por: I. I. Dedov, et al.
Publicado: (2021)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012)

Lypohypertrophy in patients receiving insulin therapy: state of the art
por: Natalya Ivanovna Volkova, et al.
Publicado: (2011)

Insulin degludec is a new ultra-long-acting insulin analogue
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
por: Olga Yuryevna Sukhareva, et al.
Publicado: (2016)

Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
por: Irina A. Kurnikova, et al.
Publicado: (2018)

Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
por: Vadim V. Klimontov, et al.
Publicado: (2018)

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
por: Yury Ivanovich Suntsov
Publicado: (2012)

The effects of structured self-monitoring of blood glucose on therapeutic effectiveness and adherence in patients with type 2 diabetes mellitus initiating insulin treatment
por: Lyudmila Alexandrovna Suvorova, et al.
Publicado: (2013)

Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
por: Yury Ivanovich Filippov, et al.
Publicado: (2012)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
por: Nina Viktorovna Bolotova, et al.
Publicado: (2010)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
por: Elena Valer'evna Biryukova
Publicado: (2011)

Can simple intensification of therapy with modern two-phase insulin help in type 2 diabetes when target glycemia failed to be achieved withbasal insulin? Results of subanalysis in the PRESENT study
por: Ch S Yang, et al.
Publicado: (2009)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
por: Vladimir Ivanovich Zoloedov, et al.
Publicado: (2012)

Therapeutic training: past, present and future
por: Alexander Sergeevich Ametov, et al.
Publicado: (2012)

Intraperitoneal insulin infusion: on the way to the artificial pancreas
por: Vladimir Aleksandrovich Karpel'ev, et al.
Publicado: (2015)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
por: Elena Efimovna Petryaykina, et al.
Publicado: (2009)

Insulin therapy during pregnancy in women with type 1 diabetes
por: V V Potin, et al.
Publicado: (2009)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
por: Ivona Renata Yarek-Martynova, et al.
Publicado: (2011)

Functional activity and peripheral insulin resistance in patients with different types of onset of diabetes mellitus
por: Tatiana Vasil'evna Nikonova, et al.
Publicado: (2012)

Early insulin therapy Coordination Council
por: Marina Vladimirovna Shestakova
Publicado: (2012)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
por: Elena Alexandrovna Kharlashina, et al.
Publicado: (2011)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
por: Tatiana Evgen'evna Taranushenko, et al.
Publicado: (2012)

Selected aspects of insulin pump therapy and continuous glucose monitoring in real time (in relation to the letter of E.D.Gorbachev)
por: Yury Ivanovich Filippov, et al.
Publicado: (2010)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2010)

Vildagliptin: optimal control in type 2 diabetes mellitus treatment
por: Alexander Sergeevich Ametov
Publicado: (2015)